Objective: Arterial stiffness and inflammation may contribute to enhanced cardiovascular mortality of dialyzed patients.Our aim was the examination of the association between inflammatory factors, arterial stiffening and cardiovascular complications in patients on permanent hemodialysis modalities. Methods: We studied 76 dialyzed patients, 47 males and 29 females.Patients were separated as regular haemodialysis (HD, n=34) and predilution haemodiafiltration (HDF, n=42) according to treatment modalities.Cardiovascular disease was defined by coronary disease (CD) and peripheral vascular disease (PVD).Arterial stiffness was measured as carotid-femoral pulse wave velocity (c-f PWV) and pulse pressure (PP) was derived.Beta2-microglobulin (beta2M), insulin, leptin, i-PTH concentrations were measured using immunoradioassay.Monocyte chemoattractant protein-1 (MCP-1) and hsCRP were measured by ELISA.Serum bicarbonate concentrations were measured using a blood gas analyzer and the ratio of cholesterol / HDL were calculated. Results: The patients with CD and the patients with PVD presented significantly higher PP and cfPWV, than those without CD or PVD.We observed significantly positive association between cfPWV, PP, age and hsCRP (p<0.05), without multicollinearity.Serum bicarbonate concentrations were inversely associated with both, c-fPWV and hsCRP (r=-0.719, p=0.001 and r=-0.349, p=0.01 respectively). hsCRP was positively correlated with leptin concentrations (r=0.283, p=0.02) and MCP-1 with the ratio chol/HDL (r=0.277, p=0.01). Conclusions: hsCRP, as an inflammatory marker, associated with leptin concentrations, may contribute to arterial stiffness of patients on hemodialysis with cardiovascular complications.Uremic acidosis promoting the inflammation may contribute to arterial stiffness.MCP-1 was mainly associated with lipid concentrations
INTRODUCTION-AIM
It has been established that cardiovascular disease is the leading cause of morbidity and mortality among dialyzed patients and it may be explained by a unique accumulation of risk factors for atherosclerosis [1] .Accelerated atherosclerosis in these patients appears to be caused by a combination of inflammation, oxidative stress, malnutrition and genetic components [2] .
The majority of deaths among dialyzed patients is related to vascular occlusive disease defined by myocardial infarction, cerebrovascular strokes and ischemic events of the limbs. The underlying disease that leads to these events, progresses through various mechanisms including left ventricular hypertrophy, plaque formation, arterial stiffening and endothelial dysfunction [1] . Although coronary atherosclerosis is a well-known underlying cause of cardiovascular disease, arterial alterations include more widespread vascular changes that contribute to stiffening of arteries. Arterial hardening causes increased pulse wave velocity (PWV) and increased pulse pressure (PP) [3] .
Several bioactive uremic toxins may be linked to inflammation, malnutrition and vascular disease, and their removal based on diffusion and convection may affect the patients survival [4] .
The aim of the present study was the examination of the association between inflammatory factors, arterial stiffening and cardiovascular complications in patients on permanent hemodialysis modalities.
SUBJECTS AND METHODS

Subjects
We studied 76 hemodialyzed patients (haemodialysis mean duration=7.3 6.0 years) who provided informed consent prior to participation in the present study. Patients with significant infection or malignancy were excluded from our study. Also, we excluded the patients with multiple intradialytic hypotensive episodes, chronic persistent hypotension, fibrillation, need to change blood pressure medications and the patients with interdialytic weight gain of >5% of total body weight. 47 men and 29 women participated in this study, on mean age 62.2 15 years old. Two modes of treatment were applied, regular hemodialysis (HD, n=34) and online-predilution haemodiafiltration (online HDF, n=42). The treatment was performed 3-times weekly with a dialysis time of 3.5-4 h per session, a filter of 1.5-2 m 2 surface area and a blood flow of 350-400ml/min. A bicarbonate-based ultrapure buffer dialysis solution was used with a dialysate flow rate of 500-600ml/min, a calcium concentration of 1.50-1.75mmol/L and a sodium concentration of 138-145mmol/L. Also, we prescribed sodium profiling or combination of sodium and ultrafiltration profiling, when it was necessary for better hemodynamic stability of patients during treatment session.
The enrolled patients had a good status and they did not have interdialytic peripheral oedema, high blood pressure, interdialytic orthostatic hypotension or other characteristics of an inaccurate dry body weight. However, they suffered from chronic hypertension (n=29), coronary disease (CD, n=25) and peripheral vascular disease (PVD, n=31).
We used synthetic high-flux membranes, defined by a ultrafiltration coefficient >20 ml/h [5] in the enrolled patients. The material of our membranes were polysulfone, ethylenevinyl alcohol, polyetherosulfone and polyamide. Dialysis dose defined by Kt/V for urea, which was calculated according to the formula of Daugirdas [6] . 20 studied patients disposed urine volume up to 100ml/day.
The primary renal diseases were hypertensive nephrosclerosis (n=25), chronic glomerulonephritis (n=23), polycystic kidney disease (n=9), diabetic nephropathy (n=7), and other/unknown (n=12).In our data, the renal failure was caused by hypertensive nephrosclerosis at a ratio 33% and by chronic glomerulonephritis at a ratio 30%. This study was approved by the ethics committee of the hospital.
Haemodynamic measurements
Predialysis peripheral systolic and diastolic blood pressures (SBP and DBP) and heart rate were calculated as a mean of 10 measurement during a treatment month using an automatic sphygmomanometer OMRON M4-I (Co Ltd Kyoto Japan).Mean peripheral pre-dialysis BP (MBP) was calculated as : (systolic BP + diastolic BP)/2.
Before of the mid-week dialysis session, the patient was positioned in the supine position and allowed to rest for at least 10 minutes prior to their haemodynamic measurements [7] .
Arterial stiffness was measured as carotid-femoral pulse wave velocity (c-f PWV) and carotid augmentation index (AIx) using the SphygmoCor system® (AtCor Medical Pty.Ltd, Sydney, Australia).In each subject two sequences of measurements were performed, and their mean was used for statistical analysis [8] .
Central systolic blood pressure (cSBP), diastolic blood pressure (cDBP), mean blood pressure (cMBP), pulse pressure (PP), and the time of return of the reflected wave (Tr) were derived. Pressure and time of first peak (P1 and T1) and second peak (P2 and T2), and central augmented pressure (AP) were obtained. Central augmentation index (AIx) was computed (AP= P2-P1; AIx = (AP/PP) x 100 ) and corrected for a heart rate of 75 beats/minute. Additionally, we measured the systolic pressure in both sides of the lower extremities, using a Doppler machine by Huntleigh Healthcare Ltd, UK.Ankle-brachial blood pressure index (ABPI) was calculated as the ratio of the lower values of ankle systolic pressure (pre or posttibial artery), divided by stabilized arm systolic pressure. ABPI values less than 0.9 were rated as low assessing PVD and values up to 1.2 were rated as high.
Laboratory measuments
Blood was drawn just before the start of the mid-week dialysis session in a fasting state from the vascular access.In the end of the treatment the blood pump speed was reduced to <80ml/min and blood samples was obtained at 2 min postdialysis from the arterial dialysis tubing.The blood samples were centrifuged and they were retained in a temperature -80 o C. The concentrations of beta2M were measured using a competitive radioimmunoassay (Immunotech by Beckman, Czech Republic) with a reported interassay coefficient of variation below or equal to 7,5%.
Normalized protein catabolic rate for dry body mass (nPCR) was calculated from the urea generation rate [9] . Body mass index (BMI) was obtained from height and postdialysis body weight.
Albumin, cholesterol, triglycerides, high density lipoproteins (HDL), sodium (Na + ) in the start and in the end of the treatment session concentrations were measured by biochemical analysis.The sodium removal was determined as percent sodium removal (PSR) using the following formula: (Na + pre -Na + post / Na + pre ) x 100.
The ratio of cholesterol / HDL was calculated, LDL concentrations were determined from the Friedewald equation [10] and metabolic acidosis was defined by serum bicarbonate concentrations, which were measured using a gas analyzer (Roche, combas b 121) taking care of the blood specimens [11] .
Insulin, leptin and i-PTH concentrations were measured using immunoradiometric assays (BioSource Europe S.A., Belgium), (Active Human Leptin IRMA DSL23100i, Webster, USA) and (CIS bio international/France) respectively.
High sensitivity C-reactive protein (hsCRP) concentrations were measured using enzyme linked immunoabsorbed assay (ΕLISA, Immundiagnostik AG., Germany) and monocyte chemmoatractant protein-1 (MCP-1) serum concentrations were also measured by ΕLISA (Alpco Diagnostics, Anachem, USA). 
Statistical analysis
Normal distributed values were expressed as mean ± SD. Differences between mean values were assessed by using unpaired t-test for two groups. Data that showed skewed distributions were expressed as median value ± interquartile range and were compared with MannWhitney U-test.
The relationship between hemodialysis modality and coronary disease or hemodialysis modality and peripheral vascular disease was checked by x square analysis. Correlations between variables were defined by Pearson and Spearman coefficient in 15 SPSS statistical analysis. Variables that were found to have a statistical association (p<0.05) in univariate linear regression analysis were entered in the multivariate models and collinearity was tested estimating the condition indices and variance inflation factors (VIF).
RESULTS
Characteristics of the studied population are listed in table 1.
Comparing the groups of patients according to the treatment mode, we observed that the patients who were treating by HDF presented higher haemodialysis duration (p=0.004) and lower PP (p=0.008) than those on HD. Additionally, we observed lower serum bicarbonate concentrations, higher PSR, higher cfPWV, AIx, insulin and hsCRP on HD patients than on HDF patients, despite non-significant differences.
Controversially, on HD patients presented significantly higher cholesterol and triglycerides concentrations (p=0.05 and p=0.014 respectively) than the patients on HDF ( figure 1 ).The Kt/V for urea values, albumin, leptin and MCP-1 concentrations were similar in both treatment modalities.
On the other hand, the group of patients with coronary disease (n=25) presented significantly higher PP, cfPWV and AIx than the patients without coronary disease (p=0.02, p=0.001 and p=0.03 respectively) (table 2) .
Similarly, the patients with peripheral vascular disease (n=31) had significantly higher PP, c-fPWV and AIx than the patients without peripheral vascular disease (p=0.01, p=0.002 and p=0.03 respectively) and also significantly lower serum bicarbonate concentrations (p=0.004) (table 2).
The check of hemodialysis modality impact on the existence of coronary or peripheral vascular disease by x 2 analysis found out non significant relationship. Dependent variable : c-fPWV
Figure 2. Correlation between c-fPWV and hsCRP in hemodialysis patients
Figure 3. Correlation between hsCRP and serum bicarbonate levels in hemodialysis patients
Correlations PP, c-fPWV values and hsCRP, leptin and serum bicarbonate concentrations were normally distributed and the Pearson correlations showed that PP was positively correlated with the age, b2M levels and cfPWV (r=0.342, p=0.003, r=0.338, p=0.003, r=0.358, p=0.002 respectively), although it was inversely associated with Kt/V for urea (r=-0.247, p=0.03).
c-fPWV was also positively associated with the age and hsCRP (r=0.418, p=0.001 and r=0.398, p=0.001 respectively) (figure 2) and inversely with serum bicarbonate concentrations (r=-0.719, p=0.001).
Collinearity statistics showed non significant interaction between age, PP, hsCRP and c-fPWV in multivariate analysis model, supporting independed association between these factors (table 3) . hsCRP concentrations were also positively correlated with the age and leptin concentrations (r=0.235, p=0.04, r=0.283, p=0.02 respectively) and negatively correlated with serum bicarbonate concentrations (r=-0.349, p=0.01) (figure 3).
Additionally, leptin concentrations were positively correlated with insulin concentrations and BMI (r=0,477, p=0.001 and r=0.404, p=0.001 respectively).
i-PTH concentrations were positively associated with cfPWV (r=0.261, p=0.02).
MCP-1 concentrations were positively associated with the ratio cholesterol/HDL (r=0.277, p=0.01) (figure 4), which, on the other hand, was inversely correlated with ABPI (r=-0.286, p=0.013). 
DISCUSSION
Mortality remains high in patients undergoing hemodialysis compared with the general population due to the higher risk of cardiovascular death, despite advanced medical management and dialysis methods [12] . Cardiovascular disease is characterized by several cardiac and arterial disorders in patients with end-stage renal disease.
Previously, it has been reported that pulse wave velocity is an integrated index of vascular function and structure.It estimates the arterial stiffness, which is a strong predictor of cardiovascular mortality in general population and in dialyzed patients [13, 14] . Additionally, pulse wave velocity is a major determinant of systolic hypertension, increasing left ventricular afterload, left ventricular hypertrophy and left ventricular oxygen consumption. Another consequence of arterial stiffening is the decreased diastolic blood pressure, which is associated with altered timing of wave reflection and decreased coronary perfusion contributing to ischaemic heart disease [15] . Also, the decreased diastolic blood pressure in combination with the systolic hypertension result in increased pulse pressure [3] . According to the findings of this study, the patients with coronary disease presented higher c-fPWV, AIx and greater PP, than the patients without coronary disease. Similar findings were also found for the patients with peripheral vascular disease.
Peripheral vascular disease is an atherosclerotic disease, that is frequently associated with coronary disease and patients with PVD are at in increased risk of myocardiac infarction and vascular death [16] .
In the mean time, it is known that the increased blood pressure (BP) in hemodialysis patients is mainly fluid overload depended and due to the alterations in hydration status and to an inaccurate dry body weight. It is mainly characterized as increased SBP than DBP with a consequence increased PP.
In a previous study, we showed that increased PP may be a consequence mainly of hydration status alterations and fluids overload depending on dialysis modality in hemodialyzed patients, rather than a consequence of increased arterial stiffness, despite fluid overload can be associated with increased arterial stiffness [17, 18, 19] .
In present study we found significantly higher PP in patients on HD than in patients on HDF. Also, we found higher PSR and higher c-fPWV and AIx values in patients on HD compared to HDF patients, despite without significant differences, may due to the good status of the studied patients. It has been already suggested that the increased extracellular volume, BP and cardiovascular instability are mainly observed in patients on HD than those on HDF. It is also known that the significant reduction in middle molecule uremic toxins concentrations by HDF combined with the removal of small molecules is clinically relevant, due to decreased uremic toxicity [20] . Indeed, in our studied patients we noted significantly negative association between PP and Kt/V for urea, although the correlation between PP, age, beta2M concentrations and c-fPWV was significantly positive.Additionally, we observed significantly higher lipids concentrations on HD patients compared to patients on HDF and more acidosis, higher insulin and hsCRP concentrations, despite non significant differences.
On the other hand, in present study, independently on hydration status, we notified that PP, age, hsCRP and cfPWV were significantly correlated, and collinearity test did not show significant multicollinearity between them, suggesting independed association between these factors. In agreement, previous study reported significant correlation between CRP and PWV [21] . From these results, we could suggest that accelerated atherosclerosis with high c-fPWV and high PP is connected with inflammation. Atherosclerosis is considered an inflammatory disease [22] and characterized by plaques and occlusive lesions is responsible for coronary and peripheral vascular disease [1] .In addition, patients with atherosclerosis present high hsCRP and other cytokines (IL-6, TNF-α) concentrations and this may reflect the existence low rate of chronic inflammation in these patients [23] .
Previously, it has already been reported the role of metabolic acidosis on vascular calcification, as the mineral metabolism disturbances are influenced by the existing metabolic acidosis in dialysis patients [24, 25] . Additionally, it is known the positive relationship between the extent of vascular calcification and PWV and it may explain the increased cardiovascular events seen in HD patients with arterial stiffness [26] . We have already shown a significantly inverse association between c-fPWV and serum bicarbonate concentrations [17] . Also, we observed significantly lower serum bicarbonate concentrations combined with significantly higher c-fPWV in patients with PVD, than in patients without PVD.
However, the influence of acidosis on vascular calcification is complicated, acting as a stimulator of the solubility of Ca x P deposits and as a blocker of phosphate uptake by the arterial smooth muscle cells, so acidosis may attenuate vascular calcification [24, 25] . But on the other hand, acidosis promotes inflammation of the arterial wall, releasing cytokines that may induce vascular calcification [27] . In this study, we found that hsCRP concentrations presented significantly inverse association with serum bicarbonate concentrations.
In the mean time, iPTH associated with Ca x P deposits can promote vascular calcification and arterial stiffness as a final consequence of a complicated function in dialysis patients [28] . In agreement we found a significantly positive relationship between i-PTH and c-fPWV.
Moreover, it has been shown that chronic inflammation is may correlate with increased expression of leptin gene in patients with chronic renal failure [29] . However, there is a discrepancy for the relationship between increased leptin concentrations and chronic inflammation of these patients [30] . In present study; we observed significantly positive correlation between hsCRP and leptin concentrations.
Leptin is an adipocytokine, which mediates the systemic inflammatory response and insulin action resulting in insulin resistance [31] .Indeed, we noted significantly positive correlation between leptin and insulin concentrations and BMI of our patients.
In addition, it has been reported that the pathogenesis of atherosclerosis, except of leukocytes adhesion on the endothelium, includes vascular remodeling with lipid deposits and macrophages and smooth muscle cells migration and proliferation mainly induced by MCP-1, which is the most studied chemokine of the β-chemokines family.The action of MCP-1 involves effects other than as purely a chemoattractant for monocytes, with a particular role on the lessions of atherogenesis [32] .It has been suggested that MCP-1 has not only a direct effect on inflammatory response, but it also influences and it is influenced by metabolic disturbances [33] . In present study, we observed significant positive correlation between MCP-1 concentrations and the ratio cholesterol/HDL.However, previous srudies provided opposite results for the association between MCP-1 and lipids [34] .
Lipid disturbancies contribute to arterial stiffness and atherosclerosis [35] . Supportingly, we observed an inverse association between the ratio cholesterol/HDL and ABPI, the low values whose define peripheral vascular disease.
CONCLUSIONS
hsCRP, as an inflammatory marker, associated with leptin concentrations, may contribute in arterial stiffness defined by high c-fPWV in patients on hemodialysis with cardiovascular complications.Despite pulse pressure is particularly influenced by hydration status, is independently associated with increased c-fPWV as well as the age and hsCRP.Uremic acidosis promoting the inflammation may contribute to arterial stiffness.MCP-1 was mainly associated with lipid concentrations, which were lower on hemodiafiltration than on regular dialysis.
